Characteristica | Total number of patients N = 1371 | Correlation coefficient | P value of Pearson’s correlation coefficient with the change in mTSS |
---|---|---|---|
Baseline mTSS | 37.9 (56.8) | 0.025 | 0.36 |
Age, years | 51.4 (12.0) | − 0.023 | 0.39 |
Female, n (%) | 1120 (81.7) | 0.032 | 0.24 |
RA disease duration, years | 5.9 (4.9) | 0.0019 | 0.94 |
MTX dose, mg/week | 15.2 (4.4) | − 0.0021 | 0.94 |
SJC28 | 11.0 (5.1) | 0.077 | 0.0041 |
TJC28 | 15.1 (6.3) | 0.041 | 0.13 |
HAQ-DI | 1.5 (0.6) | 0.049 | 0.071 |
DAS28 (ESR) | 6.5 (0.8) | N/A | 0.022 |
SDAI | 39.9 (11.8) | N/A | 0.004 |
CDAI | 38.5 (11.4) | N/A | 0.009 |
PhGA VAS, mm | 61.9 (15.5) | 0.054 | 0.048 |
Patient global assessment VAS, mm | 61.9 (18.6) | 0.041 | 0.13 |
Patient pain assessment VAS, mm | 62.0 (19.5) | 0.043 | 0.11 |
CRP, mg/L | 13.3 (19.1) | 0.057 | 0.033 |
ESR, mm/h | 44.4 (20.4) | 0.042 | 0.12 |
RF positive,b n (%) | 1033 (75.4) | 0.024 | 0.73 |